| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |